邵东算命准点的地方蚌埠算命一条街在哪,内乡算命看事哪家准,徐州有没有算命很灵的人,碌曲哪里有看的准的看相,宣城算命比较准的地方,昌平算命比较准的人,大丰里有算命的么

BEIJING, May 21 (Xinhua) -- China's State Food and Drug Administration (SFDA) issued a circular on Friday banning the use of Nimesulide, an anti-inflammatory drug, for children under the age of 12, considering potential side-effects such as liver and kidney damage.Nimesulide is a non-steroidal anti-inflammatory drug that first became available in Italy in 1985. It is now used in more than 50 countries and regions.The drug entered Chinese markets in 1997.According to the SFDA, while common adverse reactions to the drug include vomiting and stomache, domestic and overseas statistics indicate that more severe issues are related to the drug, such as blood coagulation disorders, decreased white blood cells and damage to liver and kidney.Previously, the SFDA only prevented the use of the drug among children one year old or younger.Also on Friday, the SFDA ordered the suspension of the production, sales and use of Duxil (almitrine and raubasine compound) due to its "unobvious" efficacy.According to the SFDA, clinical research found "little" evidence proving the drug effectively improves the cognitive ability for patients suffering vascular cognitive impairment.The drug was supposed to treat symptoms related to cognition and sensory nerve damage.The moves came after a two-month nationwide campaign was launched earlier this month to probe the quality of essential drugs and ensure drug safety.Official figures show that China's National Center for Adverse Drug Reaction Monitoring received 692,904 reports of adverse reactions in 2010, up 8.4 percent compared with those in 2009.Among the total, 109,991 cases involved new or severe adverse reactions, a year-on-year increase of 16.2 percent.

BAIKONUR, Kazakhstan, April 5 (Xinhua) -- Russia launched a spacecraft with three astronauts on board from the Kazakh Baikonur space center early on Tuesday, Xinhua correspondents reported from the site.The Soyuz TMA-21 spacecraft atop a Soyuz-FG carrier rocket blasted off at 02:18 a.m. Moscow time (2218 GMT April 4), sending to the International Space Station (ISS) Russian cosmonauts Alexander Samokutyaev and Andrei Borisenko and U.S. astronaut Ronald Garn.The Russian Soyuz TMA-21 spacecraft, named after the first cosmonaut Yuri Gagarin, carrying the International Space Station (ISS) crew of U.S. astronaut Ronald Garan, Russian cosmonauts Alexandr Samokutyaev and Andrey Borisenko, blasts off at the Baikonur cosmodrome, April 5, 2011.The Soyuz TMA-21, named after the first cosmonaut Yuri Gagarin, was scheduled to dock with the ISS at 03:18 a.m. Moscow time (2318 GMT April 6) on Thursday.According to the Russian Federal Space Agency (Roscosmos), the three new crew members are expected to spend 170 days in the ISS. During the period, they will receive two U.S. space shuttles and three Russian Progress cargo ships, conduct a spacewalk and carry out over 40 experiments.The launch is dedicated to the 50th anniversary of the first flight into space in 1961 carried out by Gagarin.

BEIJING, March 17 (Xinhuanet) -- A new study has shown that gene therapy can reduce symptoms in patients with Parkinson's, media reports said Thursday.The study, published in the journal Lancet Neurology, is the first to show positive results in a test of gene therapy against a sham operation in 45 U.S. Parkinson's patients.The treated group showed a 23.1 percent improvement on a scale of Parkinson's symptoms six months after treatment, compared to a 12.7 percent improvement for patients who received sham surgery, according to the published research."Gene therapy is no longer just a theory," said Michael Kaplitt, a neurosurgeon at New York-Presbyterian Hospital and Weill Cornell Medical Center, and one of the study authors. "We are getting much closer to a reality where this treatment can be offered to patients."In patients with Parkinson's disease, their brains get overactive after losing the normal supply of a chemical called GABA. The new treatment, gene therapy, works by inserting billions of copies of a gene into patients' brains that helps them produce more GABA.Kaplitt said the results might spur similar treatments for other brain disorders like Alzheimer's, epilepsy and depression.

BERLIN, May 26 (Xinhua) -- German health officials said Thursday that cucumbers imported from Spain was one source of a recent deadly E. coli outbreak in northern states that killed three people and made hundreds sick.The Hamburg Institute for Hygiene and the Environment (HU) found that four cucumbers in a local market were contaminated by Enterohaemorrhagic E. coli (EHEC), and three of them were imported from two separate Spanish suppliers, Hamburg state health authorities said.The origin of the fourth cucumber was still under investigation, officials added.German supermarkets began to pull Spanish cucumbers off shelves Thursday afternoon following the findings in Hamburg. The food- monitoring agencies in the northern states were launching investigations on vegetable markets, the federal agriculture ministry said in a statement.Figures showed that Spain is Germany's second largest supplier of cucumbers within the European Union, accounting for some 40 percent of the country's cucumber imports.Scientists said that EHEC is a virulent strain of gut bacterium that can cause severe stomach upsets, diarrhea, stroke and coma. It would lead to kidney failure in extreme cases.Germany saw a terrible E. coli outbreak two weeks ago, starting from the northern states like Hamburg and then spreading to eastern and southern regions. German health authorities said that at least three people have died from infections, and more than 200 have been diagnosed with hemolytic-uremic syndrome (HUS), which is caused by EHEC.Germany's national disease centre, the Robert Koch Institute, suggest people avoid eating raw tomatoes, cucumbers and lettuce for a while.

LOS ANGELES, May 14 (Xinhua) -- Thousands of visitors, many of them children, went to the Jet Propulsion Laboratory (JPL) in Pasadena, California for the annual open house Saturday to experience the excitement in explorations.To many visitors, the open house is a rare opportunity to see the federally funded research and development center and the National Aeronautics and Space Administration (NASA) field center, which is close to the public. JPL is managed by California Institute of Technology.The event, themed "The Excitement in Explorations," provides visitors with the chance to share in the wonders of space through high-definition and 3-D videos, live demonstrations, interactions with scientists and engineers, and a first look at JPL's new Earth Science Center.The Earth Science Center showcases the home planet and JPL's Earth science missions. Since it was the first time open to the public, it attracted many visitors who had to wait for over an hour to get admitted.Visitors first passed by two touchscreens located on opposite walls of the facility that control real-time views of "Eyes on the Earth," an interactive 3-D visualization website. Visitors also had the opportunity to watch a movie in the 3-D theater, which seats up to 40 people.Other Open House highlights include: A chance to see the most unique car in this world before it leaves Earth: The next rover bound for Mars, Mars Science Laboratory/Curiosity, in the "clean room" before it is shipped to Florida for a November 2011 launch.JPL further runs its own "reality TV show" via live-streaming webcam: http://www.ustream.tv/nasajpl.The life-size rover models in a "Mars" test bed is another attraction and a perennial crowd-pleaser. Named the Robo-Dome, it is where visitors could see a pair of 700-pound robots gliding in a high-tech arena under artificial stars.The Robo-Dome is used to simulate complex maneuvers that could be used for future space missions.The year 2011 is an exciting year for JPL's robotic explorers. In the past twelve months, two spacecraft made close encounters of comets. This summer, the Dawn spacecraft will arrive at the giant asteroid Vesta.In 2011, JPL will launch the Aquarius satellite studying Earth' s ocean, the Juno mission to Jupiter, the Gravity Recovery and Interior Laboratory's twin spacecraft to Earth's moon, and JPL's next-generation rover - Mars Science Laboratory's Curiosity.